COMPARISON OF ERECTOR SPINA PLAN BLOCK AND THORACIC PARAVERTEBRAL BLOCK FOR PERIOPERATIVE ANALGESIA
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Erector Spinae Plane (ESP) block admistring, Thoracic Paravertebral Block administring.
- Who it may be relevant to
- Registry conditions: Paravertebral Block. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Two-Center Randomized Controlled Trial
Overview
The primary aim of this study was to compare the postoperative analgesic efficacy of thoracic paravertebral block with erector spinae plane block, which we use in thoracotomy surgeries. Secondary aims were to compare these groups in terms of Riker Agitation-Sedation Scale (RASS) scores, postoperative complications, postoperative opioid consumption, and patient satisfaction.
Interventions
- Procedure Erector Spinae Plane (ESP) block admistring
In the ESPB group, the probe was placed longitudinally at the level of the T5 transverse process, 2-3 cm lateral from the midline. The muscles were visualized superior to the transverse process ; then, the needle was inserted in the craniocaudal direction using the in-plane technique. A dose of 2 mL normal saline were injected into the two layers of the interfacial area under the erector spinae muscle, and the proper injection site was confirmed. After visualizing the linear spread of saline in - Procedure Thoracic Paravertebral Block administring
In the TPVB group, the probe was placed 2-3 cm laterally and vertically of the T5 spinous process. Once the transverse process, corresponding paravertebral space, internal intercostal membrane, and pleura was identified , the needle was inserted in the lateromedial direction using the in-plane technique. After confirmation of pleural displacement with 2 mL saline, 20 mL of 0.25% bupivacaine was administered for the block.
Primary outcome measures
- Numeric Rating Scale [Time frame: Post-operative 30 minutes, 2 hours, 6 hours, 12 hours, 24 hours]
Secondary outcome measures (3)
- Riker Agitation and Sedation Scale [Time frame: Immediately after extubation]
- Patient satisfaction score: [Time frame: Post-operative 30 minutes]
- 24-hour Tramadol usage: [Time frame: posoperative 24 hours]
Eligibility criteria
Inclusion criteria
- Patients who will undergo thoracotomy and are between the ages of 18-65
- have American Society of Anesthesiologists (ASA) risk classification I-II will be included in the study.
Exclusion criteria
- Patients who did not agree to participate in the study,
- had an infection in the application area,
- had coagulopathy,
- were morbidly obese (Body mass index (BMI)>35),
- had drug allergy,
- had chronic pain, long-term opioid use, psychiatric illness history, and required emergency surgery were excluded from the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Health Sciences University Gazi Yaşargil Training and Research Hospital — Kayapınar
Identifiers
NCT: NCT07021651 · CEM